ondansetron
Generic: ondansetron
Labeler: remedyrepack inc.Drug Facts
Product Profile
Brand Name
ondansetron
Generic Name
ondansetron
Labeler
remedyrepack inc.
Dosage Form
TABLET, ORALLY DISINTEGRATING
Routes
Active Ingredients
ondansetron 4 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
70518-3512
Product ID
70518-3512_4c0e1324-ec05-d48e-e063-6294a90af1c3
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA078152
Listing Expiration
2027-12-31
Marketing Start
2022-09-07
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
705183512
Hyphenated Format
70518-3512
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ondansetron (source: ndc)
Generic Name
ondansetron (source: ndc)
Application Number
ANDA078152 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 4 mg/1
Packaging
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-0)
- 6 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-1)
- 9 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-5)
- 15 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-7)
- 3 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-8)
Packages (5)
70518-3512-0
30 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-0)
70518-3512-1
6 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-1)
70518-3512-5
9 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-5)
70518-3512-7
15 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-7)
70518-3512-8
3 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-8)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4c0e1324-ec05-d48e-e063-6294a90af1c3", "openfda": {"nui": ["N0000175817", "N0000175818"], "unii": ["4AF302ESOS"], "rxcui": ["104894"], "spl_set_id": ["c0d827d0-333f-4187-ac75-9dc7d34b6169"], "pharm_class_epc": ["Serotonin-3 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Serotonin 3 Receptor Antagonists [MoA]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-0)", "package_ndc": "70518-3512-0", "marketing_start_date": "20220907"}, {"sample": false, "description": "6 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-1)", "package_ndc": "70518-3512-1", "marketing_start_date": "20220929"}, {"sample": false, "description": "9 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-5)", "package_ndc": "70518-3512-5", "marketing_start_date": "20231223"}, {"sample": false, "description": "15 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-7)", "package_ndc": "70518-3512-7", "marketing_start_date": "20250306"}, {"sample": false, "description": "3 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-8)", "package_ndc": "70518-3512-8", "marketing_start_date": "20250724"}], "brand_name": "Ondansetron", "product_id": "70518-3512_4c0e1324-ec05-d48e-e063-6294a90af1c3", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Serotonin 3 Receptor Antagonists [MoA]", "Serotonin-3 Receptor Antagonist [EPC]"], "product_ndc": "70518-3512", "generic_name": "Ondansetron", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ondansetron", "active_ingredients": [{"name": "ONDANSETRON", "strength": "4 mg/1"}], "application_number": "ANDA078152", "marketing_category": "ANDA", "marketing_start_date": "20220907", "listing_expiration_date": "20271231"}